Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer.

Genevieve A FasanoSolange BayardYalei ChenLeticia VarellaTessa CiglerJessica BensenhaverRache SimmonsAlexander SwistelJennifer MartiAnne MooreEleni AndreopoulouJohn NgAndrew BrandmaierSilvia FormentiHaythem AliMelissa DavisLisa A Newman

Published in: Breast cancer research and treatment (2022)

Our data support current guidelines indicating benefit from adjuvant chemotherapy in node-negative TNBC associated with T1c tumors but excellent outcomes were observed in the cases of T1a and T1b disease, regardless of whether adjuvant chemotherapy was delivered.

Keyphrases

lymph node
electronic health record
clinical practice
big data
machine learning
adipose tissue
data analysis
insulin resistance